Peer-reviewed veterinary case report
Vaccine with Babesia gibsoni P50 antigen slowed parasite growth
By Fukumoto, Shinya et al.·Published in Clinical and diagnostic laboratory immunology·2005·Obihiro University of Agriculture and Veterinary Medicine, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs.
- Species:
- dog
Plain-English summary
A group of dogs was vaccinated with a new vaccine designed to protect against Babesia gibsoni, a parasite that can cause serious illness. The dogs that received the vaccine showed lower levels of the parasite in their blood, indicating some level of protection. This suggests that the vaccine could be a promising option for preventing this infection in dogs. Further studies may help confirm its effectiveness and lead to wider use.
People also search for: dog Babesia gibsoni vaccine · symptoms of Babesia in dogs · how to prevent dog parasite infections
Abstract
This is a report of a vaccine trial directed against Babesia gibsoni infection in dogs with the use of the recombinant antigen P50. Dogs immunized with P50 showed partial protection manifested as a significantly low level of parasitemia. The results indicated that P50 is a primary vaccine candidate molecule against canine B. gibsoni infection.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/15817768/